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The variety of vital functions played by glycoproteins in many physiological and pathological
processes inspired the design of glycopeptides and the study of the effect of glycosylation on
conformation. This work reports comparative circular dichroism (CD) and Fourier transform
infrared (FTIR) spectroscopic studies on linear and cyclic Amadori and imidazolidinone-type
glycopeptides 3–8 in comparison with spectroscopic data of the non-modified flexible parent
peptides, Leu-enkephalin (H-Tyr-Gly-Gly-Phe-Leu-OH, 1) and its amide (H-Tyr-Gly-Gly-Phe-
-Leu-NH2, 2). The CD and FTIR measurements were performed in different solvents in order
to expose the structural and conformational differences caused by a keto-sugar, a rigid 5-mem-
bered imidazolidinone ring and/or cyclization. The combined application of CD and FTIR
spectroscopy allowed to evaluate the relative amount of the extended and folded conformers of
Amadori as well as imidazolidinone compounds and proved to be an effective tool for charac-
terization of their structural features leading to a deeper understanding of their conformational
behaviour.
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INTRODUCTION
Opioid peptides are responsible for a variety of proces-
ses in organisms, the best characterized of which are an-
algesia, sedation, euphoria, respiratory depression, and a
peripheral action as an antidiarrheic.1 From medicinal
chemical viewpoint, a very broad spectrum of biological
activities render endogenous opioid peptides, Leu- and
Met-enkephalin (Tyr-Gly-Gly-Phe-Leu/Met),2,3 as im-
portant targets with a good potential for further develop-
ment as therapeutic agents. Because of the very poor me-
tabolic stability of biologically active peptides, numerous
analogs have been designed to overcome pharmaceutical
and pharmacokinetic barriers in clinical drug applica-
tion.4–7
The carbohydrate moieties of glycoproteins and gly-
copeptides are believed to have important roles in their
biological activity.8,9 Among these, the structural effect
on a peptide backbone represents a major function.10,11
However, the issue of how glycosylation affects protein
or peptide structure is unclear. It was reported that car-
bohydrate moiety aids in the formation of a secondary
structure of a peptide backbone, especially the b-turn,12,13
or stabilizes the peptide backbone conformation.14,15 In
* Author to whom correspondence should be addressed. (E-mail: roscic@irb.hr)
some cases no structural change is evident,16 and in some
cases the original a-helical structure was found to be
broken,17 or perturbed.18
This work reports the comparative circular dichroism
(CD) and Fourier transform infrared (FTIR) spectrosco-
pic properties of glycopeptides 3–8 in comparison with
spectroscopic data obtained for the non-modified parent
opioid peptides, Leu-enkephalin (1) and Leu-enkephalin
amide (2) (Figure 1). One group of investigated com-
pounds are Amadori compounds 3 and 4 in which the
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Figure 1. Structures of compounds 1–8: Leu-enkephalin (Tyr-Gly-Gly-Phe-Leu, 1) and its amide (Tyr-Gly-Gly-Phe-Leu-NH2, 2) as well as
their glycoconjugates, Amadori compounds 3–5 and imidazolidinones 6–8.
linear peptide is alkylated at the N-terminal position by a
1-deoxy-D-fructose unit. Adduct 5, the cyclic analog of
compound 3, possesses an ester bond between the C-6
hydroxy group of the sugar moiety and the C-terminal
carboxy group of the peptide, 1-deoxy-D-fructofuranose
acting as a bridge between the Leu-enkephalin terminal
parts. The rigid 5-membered imidazolidinone ring is
characteristic of the second class of compounds. In these
adducts an imidazolidinone moiety connects the acyclic
sugar residue with the linear peptide chain (6, 7). The
imidazolidinone compounds 6 with D-gluco sugar pen-
titol structures are diastereoisomers with trans (6a) and
cis (6b) relative geometry of the carbon substituents at
the imidazolidinone ring moiety. In the corresponding bi-
cyclic imidazolidinone analogs 8a and 8b, a 19-mem-
bered ring is formed through an ester bond between the
primary hydroxyl group of the D-gluco-pentitolyl residue
and the C-terminus of the peptide.
The measurements were performed in different sol-
vents in order to expose the structural and conformatio-
nal differences caused by a keto-sugar, a rigid 5-mem-
bered imidazolidinone ring and/or cyclization.
EXPERIMENTAL
Glycopeptide Preparation
Leu-enkephalin (1) and Leu-enkephalin amide (2) were pur-
chased from Bachem. Amadori compounds, N-(1-deoxy-D-
fructos-1-yl)-L-tyrosylglycylglycyl-L-phenylalanyl-L-leucine
(3) and cyclo-{N-[-6)-1-deoxy-a,b-D-fructofuranos-1-yl]-
L-tyrosylglycylglycyl-L-phenylalanyl-L-leucyl-(1O} (5)
were synthesized under the conditions described by Horvat
et al.19 Imidazolidinone derivatives, N-{[2-(D-gluco-penti-
tol-1-yl)-4-(4-hydroxybenzyl)-5-oxoimidazolidin-1-yl]}
acetylglycyl-L-phenylalanyl-L-leucine (6a, trans isomer; 6b,
cis isomer) and cyclo-{N-{[2-[-5)-D-gluco-pentitol-1-yl]-4-
(4-hydroxybenzyl)-5-oxoimidazolidin-1-yl-(1O]}acetyl-
glycyl-L-phenylalanyl-L-leucyl-} (8a, trans isomer; 8b, cis
isomer) were prepared according to the reported procedure.20
N-(1-deoxy-D-fructos-1-yl)-L-tyrosylglycylglycyl-L-phenyl-
alanyl-L-leucine amide (4) and N-{[2-(D-gluco-pentitol-1-yl)-
4-(4-hydroxybenzyl)-5-oxoimidazolidin-1-yl]}acetylglycyl-L-
phenylalanyl-L-leucine amide (7, trans isomer) were obtained
as described by Ro{~i} et al.21 All compounds with the ex-
ception of 4 and 5 were desalted using an octadecylsilica
solid-phase extraction (SPE) cartridge (500 mg, 2.8 mL).
CD Measurements
Circular dichroism (CD) spectra were recorded on a Jasco
J-810 spectrometer at room temperature. A quartz cuvette
with 0.2 mm path length was used for far-UV (250–185
nm) measurements and a quartz cuvette with 10.0 mm path
length for near-UV (310–250 nm) measurements. CD spec-
tra were taken in 2,2,2-trifluoroethanol (TFE; Aldrich,
NMR grade), water and in 1:1 mixture of these solvents.
The sample concentrations ranged between 0.2–0.4 mg/mL.
FTIR Measurements
FTIR spectra were recorded on a Bruker Equinox 55 spec-
trometer at room temperature in a CaF2 cell of 0.2 mm path
length. The sample concentration in TFE was 2 mg/mL in
each measurement.
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TABLE I. CD spectral parameters, molar CD (De/dm3mol–1cm–1) and mean residue ellipticity ([q]MR / deg cm2 dmol–1) of compounds
1–5 in TFE, TFE-water (1:1) mixture and water.
Compound TFE TFE/H2O = 1/1 H2O
ë / nm Mol. CD [è]MR ë / nm Mol. CD [è]MR ë / nm Mol. CD [è]MR
1 191.5 7.37 4860 194.0 11.90 7850 196.5 7.05 4650
199.5 6.31 4160
222.0 11.09 7320 224.0 7.90 5210 223.0 6.99 4610
2 187.5 6.69 4420 190.5 5.44 3590 192.5 –3.20 –2110
201.0 –3.68 –2430 200.0 –4.24 –2800 208.5 2.74 1810
212.0sh –2.06 –1360 211.0sh –1.37 –900
227.0 4.15 2740 227.0 4.04 2670 224.0 4.76 3140
3 190.5 13.60 193.0 7.75 195.0 4.76
223.5 7.26 220.5 5.73 219.0 5.23
4 188.0 10.07 190.0 4.58 196.5 –2.39
198.5 –3.63 199.5 –6.75 209.5 2.44
212.5sh –0.87 212.5sh –1.90
226.0 3.10 227.0 1.31 219.5 3.63
5 194.5 18.31 193.0 14.98 194.0 11.04
219.0 13.05 218.5 11.25 220.0 8.06
RESULTS
CD Studies of Compounds 1–8
CD spectral parameters in TFE, water and TFE-water (1:1)
mixture of Leu-enkephalin (1), its amide 2 and their
Amadori derivatives 3–5 are summarized in Table I.
As indicated by previous CD studies, the parent un-
modified peptide Leu-enkephalin (1) is present in TFE
as an ensemble of conformers rather than one or two
prevailing ones.22,23 The far-UV spectral region is con-
tributed by the CD of the backbone amide groups and the
1La and 1Bb bands of Tyr and Phe side-chains. As shown
in Figure 2A the spectrum of Leu-enkephalin (1) differs
significantly from that of its amide (2)" indicating different
population of folded (b- and g-turns) and extended con-
formers. In TFE-water (1:1) mixture and water the sign
pattern of the spectrum of 1 remains unchanged but the
band positions and intensities are changed. The CD
spectra of 2 are rather similar in TFE and in the solvent
mixture. The spectra of 2 measured in TFE and water
differ most significantly. The negative band observed at
192.5 nm in water reflects definite contribution of unor-
dered conformation.
The CD spectra of Amadori derivatives 3 and 4 in
TFE resemble those of their parent peptides 1 and 2. In
the spectrum of 3 the positive band of 1 at 199.5 nm is
missing, the spectrum between 200 and 220 nm is
positive but unstructured (Figure 2A). The solvent de-
pendence of the CD of 3 and 4 also differs from that of 1
and 2 (Table I).
The CD spectrum in TFE of the bicyclic Amadori
derivative 5 is marked by two intense positive bands
(Figure 2A). The positive band near 220 nm is contrib-
uted by the aromatic residues as in the case of the
open-chain Amadori derivatives. The band positions do
not change significantly, but the intensities are decreased
in the solvent mixture and water. These spectral features
are compatible with high population of a type II b-turn
showing class C' CD spectrum.24
The CD spectral parameters of imidazolidinone com-
pounds 6–8 are summarized in Table II. The CD curves
in TFE generally show not too much similarity. The only
exception is cis isomer of the »free hands« compound
6b and bicyclic one 8b the CD spectra of which, with
minor alterations, feature bands with the same sign pat-
tern and intensity (Figure 2B). This suggests the
foldedness of the open »free hands« compound 6b. The
corresponding trans isomers 6a and 8a have very differ-
ent CD spectra in TFE (Figure 2B). The CD spectra of
the trans »free hands« compounds 6a (acid) and 7
(amide) are also different (Table II and Figure 2B). The
spectrum of 6a shows a broad positive band with fine
structure between 190 and 210 nm. All the other imid-
azolidinone derivatives show negative CD in this region
regardless of the trans- or cis relative orientation of the
aromatic chromophore and the sugar antennae. This like-
ly reflects difference of the foldedness of the overall
structure. Beacuse of the presence of the macroring 8a
and 8b are necessarily folded. As shown in Figure 2B,
the cis-isomers 6b and 8b have strong positive bands at
193.5 nm and near 220 nm. This may be due to the same
cis steric orientation of the aromatic chromophore and
sugar antennae. Apparently, the CD spectra of imidazoli-
dinones 6–8 are rather complicated: they are determined
by the foldedness of the peptide backbone, the environ-
ment of the aromatic chromophores and the CD contri-
bution of the imidazolidinone.
Further, it is noteworthy to observe that in the far-
UV region the long-wavelength band has opposite sign
in trans and cis imidazolidinone diastereoisomers (Fig-
ure 2B). The sign of this band appears to be dependent
on the relative orientation of the aromatic chromophore
and sugar antennae but its position and intensity are
strongly affected by the polarity of the solvent.25 In the
spectra of the cis isomers (6b and 8b) in TFE the posi-
tive bands are present only as shoulders.
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Figure 2. The far-UV region circular dichroism spectra in TFE of
compounds 1–5 (A) and 6–8 (B). The spectra were obtained at
room temperature and expressed as molar CD (De/dm3mol–1cm–1)
from 185 to 250 nm.
As reported earlier for Amadori compound 3,22 the
attachment of free sugar influences the side chain con-
former distribution of Tyr and likely Phe. In agreement
with this, CD spectra of 3–5 in the 1Lb region change
sign relative to the band of parent Leu-enkephalins 1 and
2. The most intense vibrational fine structure is observed
in the spectrum of the cyclic Amadori derivative 5 (Fig-
ure 3A).
The imidazolidinone moiety incorporated into the
structure of compounds 6–8 does not influence the posi-
tive sign of the broad 1Lb band relative to parent peptides
1 and 2, but have higher intensity in the spectra of »free
hands« derivatives 6a, 6b and 7 regardless of the rela-
tive orientation (trans or cis) of the ring substituents
(Figures 3A and 3B).
FTIR Spectroscopic Characterization of Compounds
1–8
The infrared spectra of Leu-enkephalin (1), Leu-enkephalin
amide (2), their Amadori (3–5) and imidazolidinone deri-
vatives (6–8) were taken in TFE in the 1800–1500 cm–1
spectral region, which is mainly composed of bands due
to nCO (COOH), amide I, amide II, and nas (COO–) vi-
brations (Figure 4; spectra of compounds 2 and 6b not
shown). Absorptions by the aromatic Tyr and Phe side
chains also give contribution in this spectral region. Ama-
dori compounds 4 and 5 are present as trifluoroacetate
(TFA–) salts. The strong nas (COO–) band of TFA– ap-
pears at 1675 cm–1. Band assignment is based on the
data in Scheme 1.22,26 The position of the weak bands
GLYCOPEPTIDES: CD AND FTIR SPECTROSCOPIC STUDIES 651
Croat. Chem. Acta 81 (4) 647¿656 (2008)
λ / nm
λ / nm
(A)
(B)
∆ε
/d
m
3
m
o
l–1
c m
1
–
∆ε
/d
m
3
m
o
l–1
c m
1
–
250 260 270 280 290
-0,4
-0,3
-0,2
-0,1
0,0
0,1
0,2
0,3
0,4
6a
6b
7
8a
8b
250 260 270 280 290
-0,4
-0,3
-0,2
-0,1
0,0
0,1
0,2
0,3
0,4
1
2
3
4
5
Figure 3. The near-UV region circular dichroism spectra in TFE of
compounds 1–5 (A) and 6–8 (B). The spectra were obtained at
room temperature and expressed as molar CD (De/dm3mol–1cm–1)
from 250 to 295 nm.
TABLE II. Molar CD (De/dm3mol–1cm–1) of compounds 6–8 in TFE, TFE-water (1:1) mixture and water
Compound TFE TFE/H2O = 1/1 H2O
l / nm Mol. CD l / nm Mol. CD l / nm Mol. CD
6a 195.5 3.84 194.5 3.96 196.5 5.54
200.5 5.26 204.0 4.23 202.0 6.48
210.0 3.92 209.0 4.05 212.0 5.07
217.0 1.98 215.5 2.72 219.5 3.50
229.0 –2.06 229.5 –1.15 234.0 <0.03
6b 193.5 6.37 194.5 0.94
205.5 –3.32 201.5 –2.17 202.0 –2.20
219.5 4.10 217.0 4.56 218.0 3.44
7 191.0 0.38 191.0 0.50
197.0 –4.12 198.0 –8.03 197.5sh –6.11
224.0 –4.68 228.0 –3.00 216.0 0.86
8a 193.5 0
202.0 –5.24
214.0 0 214.0 0.51 205–245 ca. 0.8
227.5 –4.25 225.5 –2.30
8b 193.5 6.14 194.0 4.90
203.0 –5.08 202.0 –7.00 201.0 –5.91
218.0 5.49 218.5 3.41 219.5 2.56
and shoulders have been confirmed or corrected by Fou-
rier self-deconvolution (FSD).
The FTIR spectra of Leu-enkephalin (1) and its
Amadori derivative (3) have been reported earlier.22 The
data measured herein are in agreement with the publish-
ed ones. The sharp component bands near 1519, 1600
and 1616 cm–1 in the infrared spectra of all analyzed
compounds are assigned to the ring vibration of Tyr and
Phe (see Scheme 1). Concerning the ionization state of
compounds 1–8, it was observed that spectra show dif-
ferences due to the NH2-peptide-COOHM NH3+-pep-
tide-COO– equilibrium in TFE. In the case of com-
pounds 1 and 3 the rather low intensity of nCO COOH
and the increase and broadening of the band below
1600 cm–1 are an indication of the predominance of in-
creased population of the zwitterionic form with COO–.
Furthermore, it appears that imidazolidinones 6a, 6b
possess higher amount of the protonated species. The
carboxylic nCO stretching vibration at 1720 cm–1 in-
creases in both diastereoisomers while the carboxylate
antisymmetric stretching band below 1600 cm–1 van-
ishes. As expected, no contributions have been observed
in these two diagnostic domains in the FTIR spectra of
amide compounds 2, 4 and 7. The macro-ring of the bi-
cyclic Amadori compound 5 as well as of diastereoiso-
meric bicyclic imidazolidinones 8a, 8b is closed by an
ester bond. In their spectra, the corresponding nCO ester
band with medium intensity turns up around 1730 cm–1.
A slightly lower frequency observed for the latter two
compounds may be due to the formation of H-bonds be-
tween the carbonyl oxygen and the neighboring hydro-
xyl groups.
As known from previous FTIR studies, Leu-enkepha-
lin exhibits in TFE an ensemble of conformations, the
main components of the amide I band were assigned to
b-sheet, g-turn, semi-open and open conformers.22 The
shape and deconvolution of the amide I component bands
of compounds 2–8 gave us some information about their
backbone conformation. In general, the FTIR spectra of
the zwitterionic compounds 1, 3 and 6a reflect in TFE
solution the presence of more folded conformers (b-
and/or g-turns) than their corresponding amide analogs
2, 4 and 7. In the case of cyclic Amadori compound 5
the nas stretching band of trifluoroacetate (TFA–) at
1672 cm–1 is overlapped with the amide I band and
dominates the spectrum. However, shoulders in its FSD
spectrum at 1646, 1638 and 1629 cm–1 are present, which
indicate the presence of turns. These findings are in
agreement with the results of CD spectroscopy measure-
ments. Evidence for the presence of the acyclic form of
reducing sugars in solution has recently been proved by
FTIR spectroscopy, the nCO band of the open-keto-chain
as well as enediol absorption being found near 1728 cm–1
and 1647 cm–1, respectively.27,28 In the case of Ama-
dori compounds 3 and 5 these spectral regions are ob-
scured by nCO bands of COOH or ester group, respec-
tively, and by the weak hydrogen bonds in the semi-open
turns in the low-wavenumber amide I region (see Scheme
1). Therefore we can not reliably estimate the contribu-
tion of the open sugar ring. No absorption band has been
observed in the »open-keto« nCO spectral domain of Ama-
dori compound 4. We presume that the ring oxygen pro-
tonation as promoter step for carbohydrate ring-opening
652 E. VASS et al.
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Scheme 1. Assignment of bands in the amide I and amide II infrared region. Data taken from Refs. 22 and 26.
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Figure 4. Experimental FTIR spectra of compounds 1, 3–5, 6a, 7, 8a and 8b (solid line) and their Fourier self-deconvolution (FSD) traces
(dashed line) assuming Lorentzian band shape and values of 30 cm–1 and 0.2 for the bandwidth and noise reduction parameters, respectively.
reaction is suppressed in compound 4 due to the absence
of the COOH group.
The »free-hands« type imidazolidinone compounds
6a, 6b and 7 comprise a heterocyclic unit as well as sug-
ar and peptide chains. The open sugar chain does not
influence the spectrum between 1500 and 1800 cm–1 but
the N-substituted lactam subunite of all imidazolidinone
compounds (6–8) has a characteristic spectral contribu-
tion below 1700 cm–1 (Figure 4).
The main spectral difference in the FTIR spectra of
the trans and cis »free-hands« imidazolidinones 6a and
6b is the increased relative intensity of the shoulder at
1690 cm–1 in the spectrum of the cis form. Furthermore,
the trans and cis isomers of the ester-bonded bicyclic
imidazolidinone compounds 8a and 8b show a great dif-
ference in the intensity and the position of the band as-
signed to the imidazolidinone cis lactam bond. In the
spectrum of the cis form (8b) there is a separated band at
1690 cm–1 (appearing at 1693 cm–1 in the FSD trace),
while the corresponding band of the trans form (8a) ap-
pears only as a shoulder near 1696 cm–1. This observa-
tion may be a sign of the presence of more folded con-
formers in the less crowded trans isomers in which, due
to formation of turn(s), the nC=O...HNR band of the intra-
molecularly hydrogen bonded exocyclic carbonyl group
is shifted to the lower spectral region.
DISCUSSION
The majority of small linear peptides of biological im-
portance, like Leu-enkephalin, in aqueous solution are
present as mixtures of rapidly interconverting conform-
ers. Traditionally, CD experiments in organic solvents such
as halogenated alcohols are used for exploring their ten-
dency to adopt a detectable or even predominant amount
of intra-H-bonded folded structures.29 Besides, halogenat-
ed alcohols have been suggested to mimic the microenvi-
ronment established by apolar proteins or membranes.30
In general, the CD and FTIR spectra of the zwitter-
ionic peptide Leu-enkephalin 1, Amadori derivative 3
and trans-isomer of the »free hands« imidazolidinone 6a
reflect in TFE solution more expressed foldedness than
their corresponding amide analogs 2, 4 and 7, respec-
tively. According to the literature,26 based on informa-
tion obtained by CD, FTIR and/or NMR spectroscopy,
there are no general rules on which glycosylation influ-
ences structural propensities of parent peptides, so it can
alter backbone conformation to different degrees. Based
on the far-UV CD spectra (190–250 nm), the keto-sugar
attached to the N-terminus of enkephalins in compounds
3 and 4 does not have a significant effect upon the back-
bone conformer equilibrium of the parent peptides.
While in the far-UV range information related to the
secondary structure of the peptide backbone can be ob-
tained, in the near-UV spectral region, between 250 and
300 nm, the CD of most peptides/proteins is dominated
by the contributions of the aromatic amino acids Phe, Tyr
and Trp, and by the disulfide chromophore of cystine.31,32
Tyr has lower symmetry than Phe and therefore has more
intense absorption band in the 270–290 nm UV-range.
The opposite, negative sign of the 1Lb band in the CD
spectrum of the Amadori compounds can be explained
by the difference in the orientation of the Tyr side chain.
1Lb transition has been found to be extremely sensitive
in both sign and magnitude to rotation about the Cb-Cg
bond.33
It is an intriguing question whether or not the imid-
azolidinone ring, acting as a bridge between the carbo-
hydrate and peptide antennas in the studied compounds
6–8, has a significant contribution to their conformer
distribution. Correlation between the conformational ge-
ometry and the sign of Cotton effect (CE) of simple
a-amino acid 4-imidazolidinones and 5-oxazolidinones,
respectively, have been studied earlier on the basis of
their CD spectra.25,34 It was concluded that the sign of
the np* lactam band depends on the envelope confor-
mation of this five-membered heterocyclic ring and the
position and type of the attached bulky substituents. Be-
cause of the complexity of compounds 6–8 and overlap-
ping of n* transition bands with the 1La bands of Tyr
and Phe side-chains, it is hard to draw a clear-cut con-
clusion. However, since in the long-wavelength far-UV
region of imidazolidinones CD spectra, all trans deriva-
tives possess negative CE while the corresponding cis
isomers have positive CE, it is reasonable to presume
that these findings allow for stereochemical correlation
and makes possible to distinguish between trans- and
cis-substituted imidazolidinones. The imidazolidinone
moiety incorporated into the structure of compounds 6–8
does not change the positive sign of the broad 1Lb band of
the parent peptides 1 and 2 in the near-UV CD spectra.
In FTIR spectra, the N-substituted lactam subunite
of all imidazolidinone compounds (6–8) has a character-
istic contribution below 1700 cm–1. Based on literature
data, angular ring strain of the 5-membered heterocyclic
imidazolidinone and oxazolidinone molecules, shifts the
carbonyl stretching frequency into the higher spectral re-
gion by the order of 20–30 cm–1, compared to their acy-
clic analogs.35,36 With a decrease in the bond angle, the
carbonyl stretching mode should appear at higher fre-
quency, since it is more difficult for the carbon atom of
an exocyclic carbonyl group to move into the ring dur-
ing a cycle of nCO due to the restriction of the movement
of the two adjacent atoms. Besides, the molecular orbital
calculations led to the conclusion that in conjugated cy-
clic p-electronic molecular systems increase of angular
strain is accompanied by bond hybridization changes which
are reflected in higher stretching force constants and fre-
quencies.35 The cis lactam band between 1690–1700 cm–1
in the spectrum of the trans and cis »free hands« and
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bicyclic imidazolidinone diastereoisomers, differs in po-
sition and intensity indicating different population of
folded and extended conformers.
Due to their limited ability to form secondary struc-
tures such as a-helix, b-sheet, or random coil, cyclic
peptides are very good models for turn(s).37,38 The most
intense band in the IR spectrum, the amide I band (car-
bonyl stretching coupled with in-plane NH bending and
CN stretching modes, around 1695–1610 cm–1), consists
of a series of overlapped component bands which occur
as a result of the secondary structures present in pepti-
des. The analysis of the amide I band permits to deter-
mine the peptide secondary structures. The low wave-
number shoulder of the amide I band may be a sign of
the spectral contribution of turn(s). The amide I compo-
nent band of the acceptor CO of intramolecular H-bond(s)
of b-turns [14 (C10) H-bonding] and g-turns [13 (C7)
H-bonding] was suggested to appear near 1640 and
1620 cm–1, respectively.24 Accordingly, FTIR spectro-
scopy has a unique power to detect turns in small and
midsize peptides. Moreover, the CD/FTIR approach was
already applied for detection of turns in glycosylated
peptides.22,26,38,39 Accordingly, the CD and FTIR spec-
tral features of the bicyclic Amadori 5 derivative are com-
patible with high population of a type II b-turn.
It is shown in this paper that CD and FTIR spectro-
scopy represent an effective tool for studying the influ-
ence of the sugar residue, a rigid 5-membered imidazoli-
dinone ring and cyclization on the structural and confor-
mational features of parent unmodified peptides. The
combined application of these two techniques allowed to
evaluate the relative amount of the extended and folded
conformers of Amadori compounds 3–5 as well as imi-
dazolidinones 6–8.
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SA@ETAK
CD i FTIR spektroskopska istra`ivanja ugljikohidratnih derivata opioidnih peptida
Elemér Vass, Miklós Hollósi, [tefica Horvat i Maja Ro{~i}
Va`nost i raznolikost funkcija glikoproteina u mnogim fiziolo{kim i patolo{kim procesima potakla nas je
na dizajn novih tipova glikopeptidnih molekula i na istra`ivanje utjecaja glikacije na konformacijska obilje`ja
ishodnih peptida. U ovom su radu prikazani rezultati CD i FTIR spektroskopskih istra`ivanja strukturno razli~i-
tih linearnih i cikli~kih glikopeptida, Amadorijevih i imidazolidinonskih spojeva 3–8, te uspore|eni sa spektro-
skopskim svojstvima ishodnih peptida, Leu-enkefalina (H-Tyr-Gly-Gly-Phe-Leu-OH, 1) i Leu-enkefalin amida
(2). CD i FTIR mjerenja provedena su u razli~itim otapalima u nastojanju da se utvrde utjecaji keto-{e}era,
rigidnog 5-~lanog imidazolidinonskog prstena i/ili ciklizacije na strukturna i konformacijska obilje`ja peptida.
Primjenom CD i FTIR spektroskopije uspjeli smo odrediti relativnu zastupljenost istegnutih i savijenih konfor-
mera Amadorijevih i imidazolidinonskih spojeva i dokazali da uporaba ovih tehnika predstavlja dobar alat za
strukturnu karakterizaciju i dublje razumijevanje njihovih konformacijskih obilje`ja.
656 E. VASS et al.
Croat. Chem. Acta 81 (4) 647¿656 (2008)
